ALCON AG

NYSE: ALC (Alcon Inc.)

Kemas kini terakhir: 23 jam lalu

74.11

0.47 (0.64%)

Penutupan Terdahulu 73.64
Jumlah Dagangan 4,758,318
Harga / Pendapatan (P/E Ke hadapan) 18.36
Harga / Jualan (P/S) 3.30
Harga / Buku (P/B) 1.64
Julat 52 Minggu
61.84 (-16%) — 87.64 (18%)
Hasil Dividen (DY TTM) 0.49%
Margin Keuntungan 11.28%
Margin Operasi (TTM) 13.30%
EPS Cair (TTM) 2.25
Pertumbuhan Hasil Suku Tahunan (YOY) 0.60%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 41.10%
Jumlah Hutang/Ekuiti (D/E MRQ) 23.63%
Nisbah Semasa (MRQ) 2.70
Aliran Tunai Operasi (OCF TTM) 2.12 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.18 B
Pulangan Atas Aset (ROA TTM) 2.74%
Pulangan Atas Ekuiti (ROE TTM) 5.23%

AISkor Stockmoo

2.2
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Harga rendah berbanding pertumbuhan perolehannya. info
Pertumbuhan Tersirat info NA
Lebih murah daripada penilaian biasanya. info
Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info
Pulangan di bawah kos modalnya. Pulangan atas modal meningkat. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Aliran menurun sepanjang tahun lalu. Agak di bawah paras tertinggi 52 minggu. info
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga hampir dengan purata itu. info
Corak Lilin info NA
Di atas garis aliran jangka sederhana. info
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Berita terkini bercampur atau neutral. info
Aktiviti Orang Dalam info NA
Institusi bersih +6.45% daripada saham dalam pemfailan 13F terkini: 281 pemegang menambah, 334 mengurang (suku berakhir 30 Sep 2026). info
Persekitaran pasaran berhati-hati. info
Sektor mengatasi prestasi pasaran.
Tonggak-tonggak sependapat, jadi skor diperkukuh.
Harga hampir dengan purata 52 minggunya. Turun dalam tempoh 5 tahun. info
Momentum jangka pendek meningkat. info
Harga di antara sokongan dan rintangan. Paras sokongan dan rintangan menaik. info
Skor Akhir 2.21
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Bercampur
Stok Alcon Inc. Bercampur Menurun

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
ALC - 0.49% - 1.64
STVN - 0.30% - 2.39
RMD - 1.08% - 5.66
BDX - 2.20% - 2.41
WST - 0.37% - 9.67
BLCO - - - 1.17

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Large Growth
% Dimiliki oleh Orang Dalam 0.13%
% Dimiliki oleh Institusi 68.26%

Pemilikan

Nama Tarikh Syer Dipegang
Ako Capital Llp 30 Sep 2026 8,621,232
Zurcher Kantonalbank (Zurich Cantonalbank) 30 Sep 2026 8,013,373

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Institusi

Pemilikan institusi: 58.20%

Kedudukan Pemegang Saham
Bertambah 281 45,423,731
Berkurang 334 29,979,026
Baharu 87 20,839,836
Dijual habis 88 5,134,527

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

4 Positif 3 Negatif 6 Neutral
Tarikh Jenis Butiran
12 Nov 2026 Yahoo Finance Are Q3 Results Altering The Investment Case For Alcon (SWX:ALC)?
Alcon reported Q3 2026 revenue of US$2.74b and net income of US$260 million, alongside a revised full year 2026 net sales growth outlook of about 6%. The business is relying more on Surgical equipment and Vision Care momentum. At the same time, U.S. premium IOL competition and slightly tighter…
12 Nov 2026 Yahoo Finance Alcon (SWX:ALC) Stock Could Be 47% Undervalued After Neurotech Acquisition
Alcon has delivered mixed share performance in recent years, and the question for you now is whether the current price lines up with what its cash flows can support. With fresh product approvals and an acquisition reshaping its eye care portfolio, the stock invites a closer look at what the…
12 Nov 2026 Yahoo Finance What Could Alcon (SWX:ALC) Q3 Sales And New Deal Mean For Growth?
Alcon (SWX:ALC) reported strong Q3 2026 sales performance, underscoring momentum in its core eye care operations. The firm received US FDA approvals for new intraocular lens products intended for use in cataract and vision correction procedures. Management broadened the portfolio with the…
11 Nov 2026 Yahoo Finance Alcon: 3 Key Takeaways for Long-Term Investors
Alcon's defense of its premium lens franchise against competitor trials is the test that will decide whether its growth holds up.
11 Nov 2026 Yahoo Finance Alcon Inc. (ALC) Q3 2026 Earnings Call Transcript
Alcon narrows 2026 guidance as its Neurotech retina deal closes.
11 Nov 2026 Yahoo Finance Alcon Inc (ALC) (Q3 2026) Earnings Call Highlights: Solid Sales Growth and Margin Expansion ...
Alcon Inc (ALC) delivered 5% sales growth and 15% core EPS growth in Q3 2026, driven by equipment and ocular health strength, while navigating implantable softness and narrowing full-year guidance.
11 Nov 2026 Yahoo Finance Alcon Stocks Fall 4% After Lens Implant Sales Slip and Guidance Narrows
U.S. competition pushed implantables down 2%, and Alcon trimmed the top of its 2026 core EPS growth range.
11 Nov 2026 Yahoo Finance ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
Alcon's Q3 earnings top estimates as sales miss, margins expand and 2026 growth targets narrow; shares slip after the report.
11 Nov 2026 Yahoo Finance Alcon Inc. Q3 2026 Earnings Call Summary
Moby summary of Alcon Inc.'s Q3 2026 earnings call…
10 Nov 2026 Yahoo Finance Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth
GENEVA, November 10, 2026--Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth…
05 Nov 2026 Yahoo Finance Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Alcon (ALC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026…
05 Nov 2026 Yahoo Finance Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Alcon (ALC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
04 Nov 2026 Yahoo Finance Alcon Inc. (ALC) Is Positioned to Benefit From Long-Term Healthcare Demand: Here’s the Investment Case
Pershing Square Inc. recently released its Q3 2026 investor letter. A copy of the letter can be downloaded here. The letter reported 13% year-over-year growth in third-quarter fee-related earnings (FRE) to $63.7 million, while distributable earnings (DE) before taxes increased 8% to $61.0 million.…
Papar semua
Hasil Dividen (DY TTM) 0.49%
Purata Hasil Dividen 5T 0.20%
Nisbah Pembayaran 11.81%
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
14 May 2024 08 Apr 2024 16 May 2024 0.2644 Tunai
10 May 2023 30 Mar 2023 12 May 2023 0.2356 Tunai
29 Apr 2022 24 Mar 2022 05 May 2022 0.2083 Tunai
04 May 2021 24 Mar 2021 06 May 2021 0.0909 Tunai

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2024 0.264 1 0.31
2023 0.236 1 0.30
2022 0.208 1 0.30
2021 0.091 1 0.10

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan
Dagangan
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga hampir dengan purata itu.
Sokongan terdekat: 69.86 – 71.97 · paras kukuh
Rintangan terdekat: 71.94 – 74.40 · paras kukuh

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda